Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, ...
This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled corticosteroids. BOSTON — Compared with 17,800 patients starting new inhaled COPD ...